Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (986)	1/21/1998 10:13:00 PM
From: Scott Pratho	Respond to of 1359

I just found a very nice on-line obesity newsletter: obesity-news.com It's worth a look. One of the quotes: "New data has surfaced recently indicating that fenfluramine and heart valve damage is not nearly as common as reported by the Food and Drug Administration (FDA). Tests by doctors on 750 patients at 21 medical sites across the US, suggest that the rate of heart valve disease in patients taking phen/fen is substantially less than the 30 percent found in the FDA study. Dr. Daniel Kulick of Mission Internal Medical Group, Mission Viejo, CA said, "I think this is a real issue, but I strongly doubt the incidence [of heart valve disease] is anywhere near as high as a third". Dr. Kulick performed echocardiograms on 50 of his patients, but only one satisfies the FDA criteria for heart-valve leakage." I agree, all we have to do is refer to the decade of European experience with their 11 million patients. BTW, Neuroinvestment: I am enjoying your website.

To: NeuroInvestment who wrote (986)	1/21/1998 10:42:00 PM
From: Scott Pratho	Read Replies (1) \| Respond to of 1359

Has it been confirmed that citicoline is on the FDA fast track?

To: NeuroInvestment who wrote (986)	1/21/1998 11:14:00 PM
From: Trey Yon	Respond to of 1359

From my Doctor (of more than 15 years) who BTW has performed major surgery twice on me. Jan 15, 1998 Dear Patient, This letter is to inform you about the following recommendations from the Federal Government, which you should follow since you have been on the Phentermine/Fenfluramine weight loss medical combination. The recommendations are as follows: (1) Obtain an EKG and echcocardiogram to exclude and cardiac disease, if you have not already done so. (2) Make sure that you complete these studies with your general physician, internist, or family clinic. .......... .............. The letter fails to mention whether he is willing to foot the bill or whether insurance will cover these tests. In any case, its a pretty certain bet that either the insurer OR the patient is going to be looking to AHP, Servier & Interneuron for reimbursement of the medical tests & possible damages.